Date: 16th and 17th April 2021
Venue: Virtual Interactive
Organisers: Dr Handrean Soran & Dr Naveed Younis
For further information and course registration please follow the link:
Author: Guest Author
The Weekend SCE Revision Course- Diabetes & Endocrinology – 2021
Venue: Virtual meeting via Zoom.
Dates: 6th & 7th February 2021
We would like to invite you to a two-day educational programme on the 6th & 7th of February 2021. The Royal College of Physicians ran the first-ever SCE in Diabetes & Endocrinology in May 2009. This course has evolved over the last 11 years, the first one to run was in 2009.
This interactive programme is organized and chaired by Dr. Moulinath Banerjee, who has developed the programme over the last decade. The salient topics of Diabetes & Endocrinology curriculum will be covered. The speakers, who are all Consultants in Diabetes & Endocrinology, are listed separately with this invitation.
The number of attendees is restricted to 40. In previous years, the course has been over-subscribed, hence please register early to avoid disappointment. The course registration will close on 29th January 2021.
If you would like to attend this meeting, please register here.
Novo Nordisk, Sanofi and the 3rd sponsor (TBC) has provided sponsorship to Endocrine Wellbeing Ltd to support the costs associated with running this meeting. This includes payment of speaker and chairperson honoraria as well as administration and IT costs. No sponsor has influenced the content of the agenda topics or speaker presentations. Please do not hesitate to contact us if you have any questions.
Thanking you
The Weekend SCE Revision course team (ask.diabendo@gmail.com)
The Weekend SCE Revision Course- Diabetes & Endocrinology – 2021
Virtual meeting via Zoom
Agenda
Day 1: 6th February 2021
08.30am Zoom call opens
8.55 am Introduction: Dr M Banerjee
9.00 – 10.00 Session E1: Pituitary, MEN & miscellaneous endocrinopathies: Dr D Cuthbertson
10.00 – 11.00 Session E2: Adrenal disorders & Pregnancy with Endocrine disorders: Dr B Issa
11.00 – 11.15 Coffee break
11.15 – 12.15 Session E3: Reproductive endocrinology: Dr J T Krishnamurthy
12.15 – 13.00 Lunch [Includes 12.15-12.25 and 12.25-12.35 – 2 sessions of interaction with sponsors]
13.00 – 14.00 Session E4: Thyroid disorders (except thyroid cancers): Dr M Kashif
14.00 – 15.00 Session E6: Pituitary disorders: Dr K Kaushal
15.00 – 15.15 Coffee break
15.15 – 16.15 Session E7: Paediatric & Transitional Endocrinology: Dr Helena Gleeson
16.15 – 17.15 Session D1: Diabetes – General: Dr S Rajbhandari
17.15 – 18.15 D3: Diabetes – special circumstances: Dr M Banerjee
Day 2: 7th February 2020
8.00 am Zoom call opens
8.15 -9.15 Session E5: Thyroid cancers and nodules: Dr A Mukherjee
9.15 – 10.15 Session D3: Diabetes – complications: Dr N Younis
10.15-10.30 Coffee break
10.30 -11.30 Session M1: Electrolyte disorders: Dr S Adam
11.30 – 12.30 Session M2: Calcium & bone metabolism: Dr A Basu
12.30 – 13.15 Lunch break [Includes 12.30-12.40 – 1 session of interaction with sponsors]
13.15 – 14.15 Session M3: Lipid metabolism & cardiovascular risk: Dr H Bharaj
14.15 – 15.15 Session M4: Obesity: Dr A Syed
15.15 – 16.45 Session T1: Mock exam (90 minutes – 60 questions)
16.45 – 17.30 Session T2: Discussion of Mock exam questions: Dr M Banerjee
17.30 Feedback & Conclusion
Specialty Certificate Examination Diabetes & Endocrine Revision Course tutors
Dr Moulinath Banerjee – Consultant Diabetologist/Endocrinologist, Bolton NHS Foundation Trust
Dr Safwaan Adam – Consultant Diabetologist/Endocrinologist, The Christie Hospital, Manchester
Dr Ambar Basu – Consultant Diabetologist/Endocrinologist, Bolton NHS Foundation Trust
Dr Harnovdeep Singh Bharaj – Consultant Diabetologist/Endocrinologist, Bolton NHS Foundation Trust
Prof Dan Cuthbertson – Consultant Diabetologist/Endocrinologist, Aintree University Hospital
Dr Helena Gleeson– Consultant Endocrinologist, Queen Elizabeth University Hospital – Birmingham
Dr Mohammed Kashif – Consultant Diabetologist/Endocrinologist, Royal Lancaster Infirmary
Dr Kalpana Kaushal– Consultant Diabetologist/Endocrinologist, Royal Preston Hospital, Lancashire Teaching Hospitals
Dr JT Krishnamurthy – Consultant Diabetologist/Endocrinologist, Pennine Acute Hospitals NHS Trust
Dr Annice Mukherjee – Consultant Endocrinologist, Spire Manchester Hospital.
Prof Satyan Rajbhandari – Consultant Diabetologist/Endocrinologist, Lancashire Teaching Hospitals NHS Foundation Trust
Dr Akheel Syed – Consultant Diabetologist/Endocrinologist, Salford Royal Foundation NHS Trust
Dr Naveed Younis – Consultant Diabetologist/Endocrinologist, Manchester University Foundation NHS Trust
COVID reflections: an Endocrine Registrar’s perspective
‘Gone were the preparations to attend the Endocrine Update and the Specialty Certificate Exam. Hello, instead, COVID Medical Registrar Rota.’
Venkatram Subramanian, Specialty Trainee (ST5), Diabetes and Endocrinology, Health Education England North West Deanery, reflects on the the year gone
Manchester Specialty Certificate Examination in Endocrinology and Diabetes
Date: 6th and 7th November 2020
Venue: Virtual Interactive
Organisers: Dr Handrean Soran & Dr Naveed Younis
Course Lead: Dr Handrean Soran (handrean.soran@mft.nhs.uk)
Any enquires please email the course coordinator (ManSce2020@gmail.com)
An example of what the course provides:
- More than 250 new questions will be discussed in 14 sessions covering the whole curriculum.
- Access to another ~120 questions from our pool (mock exams included).
- Focus on clinically relevant areas and popular exam topics.
- Speaker’s predictions on potential areas of interest.
- An overall update in endocrinology and diabetes.
Who should attend?
SpRs in Endocrinology and Diabetes, CMTs who plan a career in Endocrinology and Diabetes, Chemical Pathology and Metabolic Medicine trainees, any other UK based or overseas trainee or HCP who is intending to have a career in Diabetes and Endocrinology and/or planning to take the SCE exam or to improve his/her knowledge in Endocrinology and Diabetes. Primary care physicians/trainees and overseas doctors are welcome. The course provides an extensive review and update of all the Endocrinology and Diabetes curriculum.
To reserve your place:
- Complete the Registration Form.
- Payment £250.00 before 14th October 2020 (£300 after 14th October 2020): payable via below PayPal account. Please make sure you send your payment once you finish the registration to receive the confirmation . NO confirmation will be sent without receiving the payment.
- Cancellation policy: registration fee is not refundable if cancellation after 26th October 2020.
- Only 40 Places are available. First come, first served. Registration will close on 26th October 2020.
- The link to the online interactive programme will be emailed to the delegates one week in advance. The link allows only one person to join. No other people should be present except the delegate.
- Delegates should keep the camera open all the time during the course to allow best interaction. If the camera is closed or other conditions breached the delegate may be blocked.
Obesity: A critical risk factor in the COVID‐19 pandemic
Obesity is an emerging independent risk factor for susceptibility to and severity of coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Previous viral pandemics have shown that obesity, particularly severe obesity (BMI > 40 kg/m2), is associated with increased risk of hospitalization, critical care admission and fatalities. In this narrative review, we examine emerging evidence of the influence of obesity on COVID‐19, the challenges to clinical management from pulmonary, endocrine and immune dysfunctions in individuals with obesity and identify potential areas for further research. We recommend that people with severe obesity be deemed a vulnerable group for COVID‐19; clinical trials of pharmacotherapeutics, immunotherapies and vaccination should prioritize inclusion of people with obesity.
https://onlinelibrary.wiley.com/doi/full/10.1111/cob.12403
© 2020 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Research from the NW: Vitamin D Status After Bariatric Surgery
Fox A, Slater C, Ahmed B, Ammori BJ, Senapati S, Akhtar K, Ellison J, Summers LKM, Robinson A, New JP, Soran H, Adam S, Syed AA. Vitamin D status after gastric bypass or sleeve gastrectomy over 4 years of follow-up. Obes Surg 2019 | doi:10.1007/s11695-019-04318-0
Vitamin D levels are low in 4 in 5 people with obesity prior to bariatric surgery. Routine supplementation following bariatric surgery reduces rates of deficiency/insufficiency.
15th Northwest Diabetes, Endocrinology and Cardiovascular Update: 8 Dec 2018
What: 15th Northwest Diabetes, Endocrinology and Cardiovascular Update
When: Saturday, 8th Dec 2018
Where: Pendulum Hotel and Manchester Conference Centre, Weston Building, Sackville Street, Manchester, M1 3BB http://www.manchesterconferencecentre.co.uk
The nearest carpark is situated on Charles street http://www.estates.manchester.ac.uk/services/operationalservices/carparking
To register, please complete the registration form on the following website:
https://www.surveymonkey.co.uk/r/CHH6JS5
For queries: northwest.cpd@gmail.com
Applied for 5 CPD points
Organised by Dr Handrean Soran and Dr Naveed Younis
The sponsors have had no involvement in developing the content of the meeting.
The meeting is free for Health Care professionals, scientists and students.
Limited places available, please book your place as soon as possible.
Provisional Programme
| 0830–0900 | Registration & coffee | |
| 0855 | Welcome | Dr Handrean Soran |
| First session | ||
| 0900–0945 | Managing hypertension for general practitioners and physicians
i. When to treat? ii. How to treat? iii. What treatment target? iv. Should we manage hypertension in patients with diabetes differently? v. When to refer to secondary care? |
Professor Anthony Heagerty,
University of Manchester, UK |
| 0945-1030 | Chronic kidney disease
i. The impact of chronic kidney disease ii. Initial assessment of CKD in primary care iii. When to refer patients with CKD to secondary care iv. Diabetes nephropathy When to think beyond diabetes nephropathy? Initial assessment in primary care Should we combine ACEIs and ARBs? |
Professor Philip Kalra,
Salford Royal NHS Foundation Trust |
| 1030-1115 | An update on management of hyperlipidaemia
i. What is new with LDL cholesterol lowering: PCSK9 monoclonal antibodies ii. Hypertriglyceridaemia: how to manage and what is new? iii. Diabetes Dyslipidaemia iv. Statin intolerance |
Dr Handrean Soran,
Manchester University NHS Foundation Trust |
| 1115-1135 | Moderated Panel discussion | |
| 1135–1215 | Sandwich lunch & networking | |
| Second session | ||
| 1215-1300 | Making sense of clinical guidelines for diabetes in a world of obesity
i. Treatment options ii. Managing diabesity iii. When to consider metabolic surgery |
Dr Akheel Syed,
Salford Royal NHS Foundation Trust |
| 1300-1345 | Managing cardiovascular risk in patients with diabetes: Is there a role for glucose lowering agents?
|
Dr Naveed Younis,
Manchester University NHS Foundation Trust |
| 1345-1400 | Nutraceuticals in clinical practice and recent advances | TBC |
| 1410-1430 | Moderated panel discussion | |
| 1430 | End | |
11th North West Lipid & Atherosclerosis Forum: 18 Sep 2018
What: 11th North West Lipid & Atherosclerosis Forum
When: Tuesday, 18th September 2018
Where: Radisson BLU Hotel, Chicago Avenue, Manchester Airport, Manchester, M90 3RA
Programme
| 0830 – 0900 | Registration & Coffee | |
| 0900 | Welcome | Dr Handrean Soran |
| 0905 | First Session | Chairs: Dr Michael France & TBC |
| 0910–0940 | Managing hypertension: clinical guidelines and how to individualise treatment? | Professor Anthony Heagerty, University of Manchester, UK |
| 0940-1010 | A systematic evaluation of glucose lowering therapy and cardiovascular risk: past and present. | TBC |
| 1010-1040 | Optimizing treatment of Hyperlipidaemia: quantitative evaluation of UK, USA and European guidelines | Professor Paul Durrington, University of Manchester, UK |
| 1040-1105 | Case presentation
Moderated Panel discussion |
Dr Handrean Soran |
| 1105 – 1135 | Coffee and Networking | |
| 1135 | Second session | Chairs: Professor Sean Carroll and Dr Basil Iissa |
| 1135-1205 | FCS: the disease burden, diagnosis and data from gene therapy. | Prof Elisabeth Steinhagen-Thiessen, Berlin, Germany |
| 1205-1335 | Recent advances in lipid modification therapy: PCSK9i trials and new therapies for severe hypertriglyceridaemia | Dr Handrean Soran, Manchester University Hospital, Manchester, UK |
| 1235-1305 | PCSK9, LDL-R and diabetes: from molecular mechanisms to clinical implications. | Professor Giuseppe Danilo Norata, Milan, Italy |
| 1305-1315 | Panel discussion | |
| 1315 – 1400 | Lunch and Networking | |
| 1400 | Third session | Chairs: Dr Rachelle Donn and Dr Lance Sandle |
| 1400-1430 | HDL cholesterol as a therapeutic target: A critical appraisal of previous clinical trials and how can we do better? | TBC |
| 1430-1500 | Autoimmunity against HDL/apoA-1: an emergent marker and mediator of cardiovascular risk. | Prof Nicolas Vuilleumier, Geneva Faculty of Medicine, Switzerland |
| 1500 – 1515 | Coffee and Networking | |
| 1400 | Fourth session | Chairs: Dr Dermot Neely, Newcastle, UK & TBC |
| 1510-1540 | Lipid lowering nutraceuticals in clinical practice and recent advances | Prof Maceij Banach, Warsaw, Poland |
| 1540-1610 | Lipoprotein (a) as a cardiovascular risk factor: what HEART UK says? | Dr Jaimini Cegla
Imperial College, London |
| 1420–1440 | Coffee and Networking
Feedback/Close |
|
| 1550 | END |
NWES Annual Meeting: 26 June 2018
What: North West Endocrine Society Annual Meeting
When: 26 June 2018, 13:00 – 17:00
Where: Frank Rifkin Lecture Theatre, Mayo Building, Salford Royal Hospital
PROGRAM
13:00 – 13:30 Welcome and lunch
SESSION 1 CHAIR: Professor David Ray, Manchester Royal Infirmary
13:30 – 13:45 A difficult case of Cushing’s; NW Trainee presentation
13.45 – 14:30 Methionine PET, Dotatate PET, IPSS; Dr Mark Gurnell, Addenbrooke’s Hospital, Cambridge
14:30 – 14:45 Panel discussion: Interpretation of investigations
14:45 – 15:15 Coffee break
SESSION 2 CHAIR: Dr Simon Howell, Royal Preston Hospital
15:15 – 16:00 Endocrine Clinical Case Presentations: Three 15min presentations (will be selected from abstracts submitted)
SESSION 3 CHAIR: Dr Basil Issa, Wythenshawe Hospital
16:00 – 16:40 Debate: This house believes T3 / T4 supplementation has a role
For: Professor Colin Dayan, University Hospital Wales, Cardiff
Against: Dr Amit Allahabadia, Sheffield Teaching Hospitals
16:40 – 17:00 Award Ceremony Dr Tara Kearney / Dr Annice Mukherjee
17:00 Close of meeting
Federation of the Royal College of Physicians (UK) CPD credits applied for
D&E Training Day: 26 June 2018
What: D&E Training Day for Specialty Trainees
When: 26 June 2018, 09:00 – 12:30
Where: Mayo Building, Salford Royal NHS Foundation Trust
Endodiabesity 